Director · IRADIMED CORP · IRADIMED CORP — Restricted Stock Units
Side
M
Value
—
Shares
905
Price
—
Executed
Dec 11, 2025
Disclosed
Dec 12, 2025
Disclosure timeline1 days from execution to publication · legal deadline 2 business days
Dec 11 executedDec 12, 2025 disclosed
IRMD · daily
Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Option exercise — administrative, little informational value
Relative size+13 / 25
No reported dollar value · 90500.0% of prior position
Filing timing0 / 15
Disclosed 1 business day after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Scharen-Guivel Hilda Frederique filed this Form 4 reporting a option exercise of IRMD on Dec 11, 2025. It became public on Dec 12, 2025. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director
Scharen-Guivel Hilda Frederiquecik:0001950129
Issuer
IRADIMED CORPcik:0001325618
Revision history · 0
No field has changed since this record was first ingested.
